These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

276 related items for PubMed ID: 15200478

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22. Quantitative dimensions of histopathological attributes and status of GSTM1-GSTT1 in oral submucous fibrosis.
    Pal M, Chaudhuri SR, Jadav A, Banerjee S, Paul RR, Dutta PK, Ghosh B, Chatterjee J, Chaudhuri K.
    Tissue Cell; 2008 Dec; 40(6):425-35. PubMed ID: 18573513
    [Abstract] [Full Text] [Related]

  • 23. Advances in the diagnosis of oral premalignant and malignant lesions.
    Epstein JB, Zhang L, Rosin M.
    J Can Dent Assoc; 2002 Nov; 68(10):617-21. PubMed ID: 12410942
    [Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25. Genomic instability in non-neoplastic oral mucosa cells can predict risk during 4-nitroquinoline 1-oxide-induced rat tongue carcinogenesis.
    Ribeiro DA, Fávero Salvadori DM, da Silva RN, Ribeiro Darros B, Alencar Marques ME.
    Oral Oncol; 2004 Oct; 40(9):910-5. PubMed ID: 15380169
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. Methylation of p16 CpG island associated with malignant progression of oral epithelial dysplasia: a prospective cohort study.
    Cao J, Zhou J, Gao Y, Gu L, Meng H, Liu H, Deng D.
    Clin Cancer Res; 2009 Aug 15; 15(16):5178-83. PubMed ID: 19671846
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. p53 expression in oral precancer and cancer.
    Rich AM, Kerdpon D, Reade PC.
    Aust Dent J; 1999 Jun 15; 44(2):103-5. PubMed ID: 10452165
    [Abstract] [Full Text] [Related]

  • 35. Overexpression of matrix metalloproteinase-1 and -9 mRNA is associated with progression of oral dysplasia to cancer.
    Jordan RC, Macabeo-Ong M, Shiboski CH, Dekker N, Ginzinger DG, Wong DT, Schmidt BL.
    Clin Cancer Res; 2004 Oct 01; 10(19):6460-5. PubMed ID: 15475433
    [Abstract] [Full Text] [Related]

  • 36. Detection of survivin and p53 in human oral cancer: correlation with clinicopathologic findings.
    Khan Z, Tiwari RP, Mulherkar R, Sah NK, Prasad GB, Shrivastava BR, Bisen PS.
    Head Neck; 2009 Aug 01; 31(8):1039-48. PubMed ID: 19340865
    [Abstract] [Full Text] [Related]

  • 37. Oral squamous cell carcinoma: overview of current understanding of aetiopathogenesis and clinical implications.
    Scully C, Bagan J.
    Oral Dis; 2009 Sep 01; 15(6):388-99. PubMed ID: 19371401
    [Abstract] [Full Text] [Related]

  • 38. Evaluation of myofibroblasts in oral epithelial dysplasia and squamous cell carcinoma.
    Etemad-Moghadam S, Khalili M, Tirgary F, Alaeddini M.
    J Oral Pathol Med; 2009 Sep 01; 38(8):639-43. PubMed ID: 19473444
    [Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 14.